Larry Abensur

Larry Abensur is currently serving as the President and CEO at BIOSYNEX Group since June 2015, following the merger of PRODIAG & BIOSYNEX. Prior to this, Larry held the same title at DECTRA PHARM / PRODIAG from January 1994 to June 2015. Larry Abensur holds an MBA from INSEAD and a Diplôme d'ingénieur in Chimie from Chimie ParisTech - PSL.